Is India's Pharma Sector Ready to Boost Exports?
Synopsis
India's pharmaceutical sector is on an upward trajectory, with exports predicted to soar past last year's figures. As it solidifies its global reputation, the sector's growth is underpinned by strategic collaborations and government support, promising a bright future for both domestic and international markets.
Key Takeaways
Pharmaceutical exports reached $30.47 billion .
Year-on-year growth of 9.4% is recorded.
India is the third-largest global pharmaceutical producer.
Domestic market projected to grow to $130 billion by 2030.
Focus on innovation and collaboration in key segments.
New Delhi, Jan 5 (NationPress) India's pharmaceutical exports have reached $30.47 billion in FY 2024–25, marking a 9.4 percent increase year-on-year, and are poised to exceed last year's achievements in the ongoing financial year, as reported by the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) to Commerce Secretary Rajesh Agrawal on Monday.
PHARMEXCIL emphasized India's status as the third-largest global pharmaceutical manufacturer by volume and its role as a reliable supplier of affordable, quality-assured medicines to over 150 countries, showcasing the prospects for sustainable export growth.
The leadership of PHARMEXCIL engaged in a series of high-level discussions with senior officials from the Centre to explore strategic priorities, policy alignment, and opportunities for enhancing India's pharmaceutical exports, according to a statement from the trade organization.
In a separate meeting with Manoj Joshi, Secretary of the Department of Pharmaceuticals, PHARMEXCIL shared insights on the performance and growth trajectory of the pharmaceutical industry.
The domestic pharmaceutical market in India, currently valued at around $60 billion, is anticipated to reach $130 billion by 2030, according to the trade body.
Discussions with Satya Prakash L., Joint Secretary of the Department of Pharmaceuticals, centered on enhancing collaboration between industry and academia across essential areas, including clinical trials, biopharmaceuticals, vaccines, and APIs, focusing on innovation, skill enhancement, and capacity building.
The delegation also met with Lav Aggarwal, Director General of Foreign Trade, to inform him about PHARMEXCIL's significant initiatives and to request ongoing support for programs like Chintan Shivir and iPHEX 2026.
Commenting on these engagements, PHARMEXCIL Chairman Namit Joshi stated: "India's pharmaceutical sector is at a crucial turning point. With strong export momentum, a rapidly expanding domestic market, and steadfast government support, we are in an excellent position to enhance our global presence while solidifying India's reputation as a trusted 'pharmacy of the world.'"
iPHEX 2026 & PHARMEXCIL MSME Committee Chairman Nipun Jain added: "Events like Chintan Shivir and iPHEX are vital enablers for MSMEs and exporters. They not only provide market access but also promote discussions on quality, innovation, and global competitiveness."
Point of View
The consistent growth of India's pharmaceutical sector is a testament to the resilience and innovation within the industry. With government backing and a focus on quality, India is poised to further enhance its role on the global stage, reflecting a commitment to not only meet domestic demands but also to supply the world with essential medicines.
NationPress
6 May 2026
Frequently Asked Questions
What is the current value of India's pharmaceutical exports?
India's pharmaceutical exports are valued at $30.47 billion for FY 2024-25.
How much is the domestic pharmaceutical market expected to grow by 2030?
The domestic pharmaceutical market is projected to grow from approximately $60 billion to $130 billion by 2030.
Which organization reported the export figures?
The Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) reported the export figures.
What initiatives are being discussed to support the pharma sector?
Discussions are focusing on industry-academia collaboration, clinical trials, biopharmaceuticals, vaccines, and APIs.
Who is the Chairman of PHARMEXCIL?
The Chairman of PHARMEXCIL is Namit Joshi.
